Author details

Full Name

Katja K H Aben

Affiliation

ORCID

Career Start Year

1996

Papers

226

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37517601	Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide Study.	Int J Radiat Oncol Biol Phys	2024
36594579	Longitudinal associations of adherence to lifestyle recommendations and health-related quality of life in patients with non-muscle invasive bladder cancer.		2023
35835545	Interlaboratory Gleason grading variation affects treatment: a Dutch historic cohort study in 30 509 patients with prostate cancer.	J Clin Pathol	2023
36224377	Incidence and survival of castration-resistant prostate cancer patients with visceral metastases: results from the Dutch CAPRI-registry.	Prostate Cancer Prostatic Dis	2023
37852813	Long-term Overall Survival after External Beam Radiotherapy for Localised Prostate Cancer.		2023
37748112	Estimating Treatment Effect of Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer Using Bayesian Networks.	JCO Clin Cancer Inform	2023
37996278	Health-related Quality of Life During the First 4 Years After Non-Muscle-invasive Bladder Cancer Diagnosis: Results of a Large Multicentre Prospective Cohort.		2023
37800635	Body mass index and waist circumference in relation to risk of recurrence and progression after non-muscle invasive bladder cancer.		2023
37289470	Changes to Primary End Points in Randomized Clinical Trials on Immune Checkpoint Inhibitors in Urothelial, Renal Cell, and Lung Cancers: A Systematic Review.		2023
36972960	Cohort profile - the Renal cell cancer: Lifestyle, prognosis and quality of life (ReLife) study in the Netherlands.		2023
37210288	Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights.	Eur Urol	2023
37142955	Radical prostatectomy versus external beam radiotherapy with androgen deprivation therapy for high-risk prostate cancer: a systematic review.		2023
37124522	A comparison of machine learning models for predicting urinary incontinence in men with localized prostate cancer.	Front Oncol	2023
36867616	Development and external validation of multivariate prediction models for erectile dysfunction in men with localized prostate cancer.	PLoS One	2023
36693678	Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections.		2023
37246479	Staging fluorodeoxyglucose positron emission tomography/computed tomography for muscle-invasive bladder cancer: a nationwide population-based study.		2023
37187720	Minimum Volume Standards: An Incentive To Perform More Radical Cystectomies?		2023
37434119	The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designs.	BMC Cancer	2023
37369443	Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis.	Can J Surg	2023
36863459	Chemoradiation for muscle-invasive bladder cancer using 5-fluorouracil versus capecitabine: A nationwide cohort study.		2023
36688720	Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.	J Natl Cancer Inst	2023
36725405	Impact of Advanced External Beam Radiotherapy on Second Haematological Cancer Risk in Prostate Cancer Survivors.		2023
36781128	Adherence to lifestyle recommendations after non-muscle invasive bladder cancer diagnosis and risk of recurrence.		2023
36595730	Identifying Confounders Using Bayesian Networks and Estimating Treatment Effect in Prostate Cancer With Observational Data.	JCO Clin Cancer Inform	2023
34872047	Skeletal muscle radiodensity and visceral adipose tissue index are associated with survival in renal cell cancer - A multicenter population-based cohort study.	Clinical Nutrition	2022
35654644	Corrigendum to "Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study".	Urol Oncol	2022
36210504	Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.	J Natl Cancer Inst	2022
35421819	Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands.	Cancer Treat Res Commun	2022
36202890	Association of visceral and subcutaneous adiposity with tumor stage and Fuhrman grade in renal cell carcinoma.	Scientific Reports	2022
36328090	Trends and variation in the use of radiotherapy in non-metastatic prostate cancer: A 12-year nationwide overview from the Netherlands.	Radiother Oncol	2022
35778577	Sex differences in treatment patterns for non-advanced muscle-invasive bladder cancer: a descriptive analysis of 3484 patients of the Netherlands Cancer Registry.	World Journal of Urology	2022
36632160	The association of body composition with postoperative complications and length of hospital stay after radical or partial nephrectomy in patients with renal cell cancer: a multicenter population-based cohort study.		2022
34303597	Intermediate-term survival of robot-assisted versus open radical cystectomy for muscle-invasive and high-risk non-muscle invasive bladder cancer in The Netherlands.	Urologic Oncology: Seminars and Original Investigations	2022
34353775	Genome-wide Meta-analysis Identifies Novel Genes Associated with Recurrence and Progression in Non-muscle-invasive Bladder Cancer.	Eur Urol Oncol	2022
34082036	Predictors of surgical treatment burden, outcomes, and overall survival in older adults with basal cell carcinoma: Results from the prospective, multicenter BATOA cohort.	Journal of the American Academy of Dermatology	2022
34741789	Prognostic importance of concomitant non-regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer.	BJU Int	2022
35039230	Evidence or Prejudice? Critical Re-Analysis of Randomized Controlled Trials Comparing Overall Survival After Cisplatin Versus Carboplatin-Based Regimens in Advanced Urothelial Carcinoma.	Clin Genitourin Cancer	2022
34848157	Symptomatic Skeletal Events and the Use of Bone Health Agents in a Real-World Treated Metastatic Castration Resistant Prostate Cancer Population: Results From the CAPRI-Study in the Netherlands.	Clin Genitourin Cancer	2022
34535437	Overall Survival of Patients Receiving Cisplatin or Carboplatin for Primary Metastatic Urothelial Carcinoma of the Bladder: A Contemporary Dutch Nationwide Cohort Study.	Eur Urol Focus	2022
35064953	Non-metastatic muscle-invasive bladder cancer: the role of age in receiving treatment with curative intent.	BJU International	2022
34415798	High-Intensity Care in the End-of-Life Phase of Castration-Resistant Prostate Cancer Patients: Results from the Dutch CAPRI-Registry.	J Palliat Med	2021
31748122	Variation in the Prescription of Androgen Deprivation Therapy in Intermediate- and High-risk Prostate Cancer Patients Treated with Radiotherapy in the Netherlands, and Adherence to European Association of Urology Guidelines: A Population-based Study.	Eur Urol Focus	2021
32362484	Third-line Life-prolonging Drug Treatment in a Real-world Metastatic Castration-resistant Prostate Cancer Population: Results from the Dutch Castration-resistant Prostate Cancer Registry.	Eur Urol Focus	2021
33746212	The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population.	Prostate Cancer Prostatic Dis	2021
33690922	Rising incidence rates and unaltered survival rates for primary upper urinary tract urothelial carcinoma: a Dutch population-based study from 1993 to 2017.	BJU International	2021
34006553	Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the 'trials within cohorts' study ProBCI.	BMJ Open	2021
34900722	Impact of Advanced Radiotherapy on Second Primary Cancer Risk in Prostate Cancer Survivors: A Nationwide Cohort Study.	Front Oncol	2021
34542736	Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer.	J Patient Rep Outcomes	2021
31293036	Guideline adherence for the surgical treatment of T1 renal tumours correlates with hospital volume: an analysis from the British Association of Urological Surgeons Nephrectomy Audit.	BJU International	2020
31676912	The global burden of urinary bladder cancer: an update.	World Journal of Urology	2020